Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2.
作者信息
Rahimi Farid, Talebi Bezmin Abadi Amin
机构信息
Research School of Biology, The Australian National University, Canberra, Australia.
Faculty of Medical Sciences, Department of Bacteriology, Tarbiat Modares University, Tehran, Iran.
出版信息
Arch Med Res. 2020 Jul;51(5):453-454. doi: 10.1016/j.arcmed.2020.04.008. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2.
Arch Med Res. 2020 Jul;51(5):453-454. doi: 10.1016/j.arcmed.2020.04.008. Epub 2020 Apr 15.
2
Corrigendum to 'Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2'[Arch. Med. Res. 51(5) (2020) 453-454/ARCMED 2020 432].
Arch Med Res. 2023 Jul;54(5):102836. doi: 10.1016/j.arcmed.2023.06.001. Epub 2023 Jun 21.
3
Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA.
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1303-1308. doi: 10.1007/s10096-021-04159-9. Epub 2021 Jan 29.
4
Establishment and evaluation of a 30-minute detection method for SARS-CoV-2 nucleic acid using a novel ultra-fast real-time PCR instrument.
J Thorac Dis. 2021 Dec;13(12):6866-6875. doi: 10.21037/jtd-21-1288.
5
Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care.
Matter. 2021 Jul 7;4(7):2403-2416. doi: 10.1016/j.matt.2021.05.003. Epub 2021 May 9.
6
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
Med Hypotheses. 2022 Feb;159:110754. doi: 10.1016/j.mehy.2021.110754. Epub 2022 Jan 4.
7
Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care.
Mater Lett. 2021 Dec 1;304:130612. doi: 10.1016/j.matlet.2021.130612. Epub 2021 Aug 6.
8
Evaluation of diagnostic performance of SARS-CoV-2 detection kits: a comparative study.
Beni Suef Univ J Basic Appl Sci. 2023;12(1):17. doi: 10.1186/s43088-023-00360-1. Epub 2023 Feb 12.
9
SARS-CoV-2 seroprevalence in healthcare workers: The experience of a Portuguese COVID-19 front-line hospital during the 1st pandemic wave.
Porto Biomed J. 2022 Jun 17;7(3):e166. doi: 10.1097/j.pbj.0000000000000166. eCollection 2022 May-Jun.
10
Do readers use character information when programming return-sweep saccades?
Vision Res. 2021 Jun;183:30-40. doi: 10.1016/j.visres.2021.01.003. Epub 2021 Feb 27.
引用本文的文献
1
Multiplex detection of respiratory RNA viruses without amplification based on CRISPR-Cas13a immunochromatographic test strips.
Virol J. 2025 Jun 12;22(1):192. doi: 10.1186/s12985-025-02765-z.
2
SARS-CoV-2 and omicron variant detection with a high selectivity, sensitivity, and low-cost silicon bio-nanosensor.
Nano Sel. 2022 Dec 29. doi: 10.1002/nano.202200188.
3
A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
PLoS One. 2021 Nov 10;16(11):e0258819. doi: 10.1371/journal.pone.0258819. eCollection 2021.
本文引用的文献
1
Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools.
Arch Med Res. 2020 Jul;51(5):450-452. doi: 10.1016/j.arcmed.2020.04.003. Epub 2020 Apr 15.
2
Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform.
Clin Chem. 2020 Jul 1;66(7):975-977. doi: 10.1093/clinchem/hvaa102.
3
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends.
Diagnostics (Basel). 2020 Apr 5;10(4):202. doi: 10.3390/diagnostics10040202.
4
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
5
Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.
Arch Med Res. 2020 Apr;51(3):280-281. doi: 10.1016/j.arcmed.2020.03.005. Epub 2020 Mar 27.
Zotero 插件